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Secretory proteins and most membrane proteins are synthesized with a signal sequence that is usually cleaved from the
nascent polypeptide chain, during its transport, into the lumen of the endoplasmic reticulum (ER). We have analyzed the
kinetics of the cleavage of the HIV-1 Env protein signal sequence from gp160 and gp120 in HeLa, BHK, and Jurkat cells.
Furthermore, we have determined the effects of this cleavage on the association of the gp160 and gp120 glycoproteins with
the ER protein calnexin and the effects of the signal sequence cleavage on protein folding. The cleavage of the HIV-1 Env
protein signal sequence on both gp160 and gp120 occurred very slowly in all three cell lines with a t1/2 of 45–60 min. The core
glycosylated and signal-sequence-retained forms of gp160 and gp120 associated with calnexin while the signal-sequence-
cleaved forms of gp160 and gp120 had disassociated from calnexin and correctly folded as determined by their ability to
associate with the CD4 cellular receptor. Further analysis of the folding state of gp160 and gp120 in nonreducing SDS–PAGE
revealed that the signal-sequence-retained and calnexin-associated forms of gp160 and gp120 migrated as broad, diffuse
bands, whereas the signal-sequence-cleaved or CD4-associated forms of gp160 and gp120 migrated as single sharper
bands. The cause of this retardation in the rate of folding and intracellular transport of HIV-1 glycoproteins was localized to
their signal sequences by fusing the vesicular stomatitis virus G protein with the HIV-1 Env protein signal sequence and
expressing this chimeric protein in mammalian cells. The HIV-1 Env protein signal sequence on the VSV-G protein also
confers a reduced rate of cleavage and slow intracellular transport and folding of the chimeric G protein. These results
provide direct evidence that in vivo the HIV-1 glycoprotein signal sequence inhibits the folding of HIV-1 Env protein. Our data
also suggest a direct correlation between the rate of the signal sequence cleavage and protein folding. © 2000 Academic PressINTRODUCTION
Membrane proteins or proteins destined for secretion
have N-terminal hydrophobic signal sequences (Walter
et al., 1984) that are essential for targeting the nascent
polypeptide chains to the protein-conducting channel
and for their subsequent translocation across or inser-
tion into the endoplasmic reticulum (ER) membrane (An-
drews and Johnson, 1996; Johnson, 1997). In addition, a
previous report suggests that the presence of the signal
sequence may also influence the folding of the nascent
polypeptide chains (Park et al., 1988). Although no con-
sensus sequence exists for prokaryotic or eukaryotic
signal sequences, three regions with specific features
appear to be retained by all prokaryotic and eukaryotic
membrane proteins: a positively charged N-terminal n-
region, a central hydrophobic core (h-region) of 7–15
residues, and a polar C-terminal c-region that contains
the cleavage site for the signal peptidase (von Heijne,
1 Present address: Respiratory Viruses, Bureau of Microbiology, Ca-
adian Science Centre for Human and Animal Health, 1015 Arlington
treet, Winnipeg, Manitoba, Canada R3E 3R2.2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (519) 663-3682. E-mail: cykang@julian.uwo.ca.
4171985). Of the three regions defining the signal sequence,
it is the n-region that displays the greatest diversity with
respect to amino acid composition.
In the ER lumen, a nascent polypeptide chain must
acquire the correct disulfide bonds to attain functional
conformation. A further set of protein modifications occur
cotranslationally, for example, the signal sequence of a
presecretory protein is cleaved, oligosaccharyl trans-
ferase glycosylates the appropriate N-X-S/T sites, and a
rich cocktail of molecular chaperones such as BiP
(Hsp70), peptidyl-proline isomerase, and protein disul-
fide isomerase Erp57 aids protein folding and oligomer-
ization (Hurtley and Helenius, 1989; Doms et al., 1993;
Pilon et al., 1997; Reddy and Corley, 1998; Huppa and
Ploegh, 1998; Zapun et al., 1998). The ER also has a
“quality control” system that ensures that proteins do not
leave this compartment before they have reached their
native state (Hurtley and Helenius, 1989; Ou et al., 1993;
Doms et al., 1993; Huppa and Ploegh, 1998). Failure to
perform any of these steps results in the retention of the
protein in the ER and subsequently in the aggregation or
proteolytic degradation in the cytosol (Klausner and Sitia,
1990; Yang et al., 1998).The mechanisms of viral glycoprotein folding, olig-
meric assembly, and sorting have been extensively char-
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418 LI ET AL.acterized in recent years. Despite their complex tertiary
and quaternary structures, many viral membrane pro-
teins fold into assembly-competent conformations
quickly and efficiently. For example, the influenza HA and
VSV-G fold into assembly-competent conformations with
a t 1/ 2 of approximately 3 min (Doms et al., 1987; Yewdell
et al., 1988; deSilva et al., 1990; Braakman et al., 1991).
However, some viral membrane proteins fold much more
slowly and/or inefficiently; for example, the SV5 HN and
HIV-1 envelope (Env) proteins exhibit folding half-times of
20–30 min (Ng et al., 1989; Earl et al., 1991b; Li et al.,
1993), whereas the measles virus HN glycoprotein folds
even more slowly and even less efficiently; less than 50%
of the molecules have acquired processed glycans 5 h
after synthesis (Kohama et al., 1985; Cattaneo and Rose,
1993). The reasons for such marked differences in fold-
ing rates and efficiencies are not known (Doms et al.,
1993). Sequence analyses have revealed that the HIV-1
Env glycoprotein contains a novel signal sequence that
is 30 amino acids long and has an average of 5 positively
charged amino acids preceding the hydrophobic core of
the signal sequence (Li et al., 1994). However, there have
been few studies focused on the HIV-1 signal sequence
(Berman et al., 1988; Ellerbrok et al., 1992; Li et al., 1994,
1996; Martoglio et al., 1997). Using a signal sequence
gene fusion combined with a site-directed mutagenesis
approach, we have studied the role of the signal se-
quence in the biosynthesis and secretion of HIV-1 gp120
in Spodoptera frugiperda (SF9) cells and demonstrated
that the charged residues in the n-region of the signal
sequence are not necessary for efficient translocation
and maturation (Ellerbrok et al., 1992; Li et al., 1994) but
they are the key determinants of its poor expression and
secretion (Li et al., 1994). Our results suggested that the
unusually large number of positively charged amino ac-
ids in the HIV-1 Env protein signal sequence affects the
rate of cleavage of the signal peptide on gp120 and that
this is responsible for its slow rate of folding, intracellular
transport, and secretion (Li et al., 1994). Subsequently, by
coinfection of recombinant baculoviruses containing
mammalian (canine) calnexin and HIV-1 gp120 in SF9
insect cells, we have demonstrated that inefficient cleav-
age of the signal sequence on HIV-1 gp120 is directly
responsible for the ER retention of gp120 and its pro-
longed association with the molecular chaperone, cal-
nexin (Li et al., 1996). However, there is still a lack of
direct experimental evidence showing that the un-
cleaved signal peptide affects the folding of gp120. It is
important to address the question of whether or not the
slow and inefficient cleavage of the signal sequence
observed in insect cells represents a general phenom-
enon rather than an intrinsic property of a baculovirus/
insect cell expression system.
In this study, we have expressed the HIV-1 Env pre-
cursor protein gp160 and gp120 in several mammalian
cell lines including a human T cell line using the recom-binant vaccinia viruses and we have analyzed the kinet-
ics of the signal sequence cleavage and its relationship
to the Env protein folding and its association with caln-
exin. Our results demonstrate not only the slow and
inefficient cleavage of the signal sequence during the
early stage of biosynthesis of the HIV-1 Env protein but
also provide direct evidence that in vivo the uncleaved
signal sequence retards the folding of the HIV-1 Env
protein. These results clearly indicate that the cleavage
of the signal sequence is a crucial step in determining
the efficiency of subsequent folding and intracellular
transport of viral glycoprotein.
RESULTS
Processing of the signal sequence of HIV-1 Env
protein in different cell lines
To determine the role of the atypical signal sequence
in the early stages of the biosynthesis and folding of the
HIV-1 Env protein, we have used the extensively studied
HIV-1 envelope glycoprotein gp160 expressed by the
recombinant vaccinia virus vPE16 (Earl et al., 1991a) and
xamined the kinetics of the signal sequence cleavage
n three different mammalian cell lines.
HeLa, BHK21, and Jurkat cells were infected with
PE16, which expresses the full-length gp160 of HIV-1,
nd were pulse-labeled with [35S]methionine for 15 min,
fter which cells were immediately lysed or chased for
ifferent times with unlabeled medium. One-half of the
ell lysate was incubated with anti-HIV antibodies (a
ixture of HIV-positive human immune globulin and
heep anti-gp120 antibodies) to precipitate the total la-
eled Env protein, while the other half was precipitated
ith anti HIV-1 Env signal peptide serum (Li et al., 1996).
s shown in Fig. 1A, gp160 was recovered with anti-HIV
ntibodies in all three cell lines immediately after the
5-min pulse label. Although cleavage of gp160, as indi-
ated by the appearance of gp120, was slightly different
n each cell line, the amount of immunoprecipitable
p160 remained relatively constant during the chase
eriods. Only a small fraction of gp160 was cleaved to
roduce gp120, which is then slowly released into the
edium (Fig. 1A, Jurkat and BHK cells, panels Anti-HIV,
/m). This inefficient cleavage of gp160 is similar to
revious reports with HIV-1 infection and recombinant
accinia virus-infected mammalian cell lines expressing
IV-1 Env proteins (Willey et al., 1988; Earl et al., 1991b).
The majority of newly synthesized gp160 was precipi-
tated with anti-signal peptide serum immediately after
synthesis and then gradually decreased with time, indi-
cating that the signal peptide was cleaved very ineffi-
ciently in these cell lines. It was also noted that a very
small fraction of the processed gp120 was precipitated
with anti-signal peptide serum at an early time of chase
(Fig. 1A, Jurkat and BHK cells at 0 and 30 min). As the
chase progressed, however, the processed gp120 was
anti-sig
419HIV-1 ENVELOPE PROTEIN SIGNAL SEQUENCEno longer detected with the anti-signal peptide serum,
indicating that the newly synthesized and processed
gp120 retained its signal sequence. Quantification of the
radioactivity in the protein bands revealed that the t 1/ 2 of
the gp160 signal peptide cleavage was approximately 45
min in Jurkat cells and approximately 60 min in HeLa and
BHK cells (Fig. 1C). However, the amount of gp160 pre-
cipitated with anti-signal peptide antibodies is likely to
be an underestimation, since we were unable to quanti-
tatively immunoprecipitate the gp160, due to the low titer
FIG. 1. Kinetics of signal cleavage of HIV-1 Env protein. HeLa, BHK-21,
the cells were pulse-labeled with [35S]methionine for 15 min and chas
respectively, divided into two equal aliquots; one aliquot was immunopre
antibody (designated anti-HIV), while the other was precipitated with a
chase (4/m) was collected and used for analysis of secretion of gp120.
by fluorography. The amount of gp160 or gp120 precipitated with the
relative to that observed at 0 h (100%) (C and D).of the signal peptide antibody.
We have previously demonstrated that the HIV-1 gp120signal sequence is cleaved inefficiently in insect cells (Li
et al., 1996). To determine whether or not this phenom-
enon is an intrinsic property of the signal sequence on
the HIV-1 Env protein, we have used a recombinant
vaccinia virus, vPE8, which expresses the gp120 gene
(Earl et al., 1991a), to infect mammalian cells and we
have analyzed the efficiency of the signal cleavage. Anal-
ysis of pulse–chase experiments revealed that gp120
exhibited a slow rate of the signal sequence cleavage in
these cell lines similar to that observed with gp160 (Fig.
kat cells were infected with vPE16 (A) or vPE8 (B). At 16 h postinfection,
7°C for the times indicated. Cell lysates and a culture medium were,
ed with a mixture of HIV-positive human antibody and sheep anti-gp120
signal peptide antibody. The culture medium derived from only 4 h of
ulting immunoprecipitates were analyzed on SDS–10% PAGE followed
nal peptide antibody was quantified by densitometry and expressedand Jur
ed at 3
cipitat
n anti-
The res1B). Quantification by densitometry showed that approx-
imately 50% of radiolabeled gp120 retained the signal
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420 LI ET AL.sequence after 1 h of chase and about 5–10% of labeled
gp120 was still recognized by the anti-signal peptide
antibody after 4 h (Fig. 1D). Consistent with our previous
observations (Li et al., 1996), the secreted gp120 was
recipitable only with anti-HIV antibodies and not with
he anti-signal peptide antibody (Figs. 1A and 1B, Jurkat
nd BHK cells: see panels Anti-HIV, 4/m), indicating that
he secreted gp120 had its signal sequence cleaved.
hese results confirm and extend our previous observa-
ions that the slow and inefficient cleavage of the signal
eptide of HIV-1 Env protein appears to represent a
eneral phenomenon in all cell lines regardless of the
resence or absence of the transmembrane protein gp41
Li et al., 1994).
nalysis of the association of HIV-1 Env protein with
alnexin and folding
To determine the relationship between the signal se-
uence cleavage and its association with calnexin and
ubsequent protein folding, we first examined the bind-
ng kinetics of gp160 and gp120 with calnexin and CD4.
he binding of gp120 to CD4 has been used as a func-
ional assay to measure its correct configuration (Li et al.,
993, 1994; Earl et al., 1991b). HeLa cells infected with
PE16 or vPE8 were labeled with [35S]methionine for 10
min and chased with cold medium for up to 90 min. The
cell lysates were divided into four equal parts and im-
munoprecipitated with antibodies to HIV, signal peptide,
calnexin, or CD4, respectively (Fig. 2).
Compared with the total labeled gp160 precipitated
with the anti-HIV antibody (Fig. 2A), a relatively constant
amount (.50%) of the labeled gp160 was also precipi-
tated with the anti-signal peptide antibody, indicating that
the majority of newly synthesized gp160 retained the
signal sequence during this time. In contrast, coimmu-
noprecipitation experiments showed that almost all of
the labeled gp160 was coimmunoprecipitated with caln-
exin immediately after the pulse-labeling and that the
precipitable amounts of gp160 gradually decreased with
time during the chase period (Fig. 2A, panel Anti-caln-
exin). This result indicates that the majority of newly
synthesized HIV-1 Env protein interacted with calnexin
immediately after its synthesis. Quantification by densi-
tometry indicated that the t 1/ 2 for the gp160 association
with calnexin was approximately 35 min, with minimal
binding observed after 90 min (Fig. 2C). This long t 1/ 2 of
dissociation was similar to that observed by Otteken and
Moss (1996), who examined the calnexin association
with gp160 expressed by the same recombinant vaccinia
virus in BSC-1 cells. Concomitant with the dissociation of
gp160 from calnexin, the newly synthesized gp160 did
not bind to the CD4 immediately after the pulse. How-
ever, the level of gp160 binding to CD4 increased grad-
ually with the time of chase (Fig. 2A, panel Anti-CD4).
These data indicate that the newly synthesized gp160
d
premains associated with calnexin and folds slowly into a
bioactive conformation, which is recognized by CD4 (Earl
et al., 1991b; Li et al., 1993, 1994, 1996). The t 1/ 2 of folding
of gp160 as measured by this assay was approximately
35 min (Fig. 2C), which correlates with the time of gp160
dissociation from calnexin. This t 1/ 2 of folding is slower
than previously reported for gp160 (Earl et al., 1991b), a
esult that is probably due to the different cell type used,
s the authors have suggested.
When the pulse–chase experiment was performed in
PE8-infected HeLa cells, gp120 appeared in the ab-
ence of gp41, to acquire faster rates in its dissociation
rom calnexin and bound to CD4 with a t 1/ 2 of about 15
in (Figs. 2B and 2D). This is different from the other
eports that showed that the secreted analogues of
ome other membrane proteins have been found to fold
ore slowly than their membrane-anchored counter-
arts (Crise et al., 1989; Singh et al., 1990). The findings
hat the decreased level of the gp160 and gp120 asso-
iation with calnexin precisely mirrors the increase of
heir binding to the CD4 receptor clearly indicate that
nly unfolded or incompletely folded HIV-1 Env proteins
re in association with calnexin during their maturation.
o establish whether or not the correlation observed
etween calnexin association and protein folding is di-
ectly related to the signal sequence cleavage, we mea-
ured the effects of signal sequence cleavage on caln-
xin association and protein folding.
ffects of signal sequence cleavage on calnexin
ssociation and protein folding
HIV-1 gp160 and gp120 contain approximately 30 and
0 potential N-linked glycosylation sites, respectively,
nd the N-linked glycans represent almost 50% of the
pparent molecular mass of the protein (Allan et al.,
985). Therefore, it is not possible to resolve, by SDS–
AGE under reducing conditions, the signal-cleaved form
rom the signal-retained form of gp160. To distinguish
etween the signal-cleaved form from the signal-re-
ained form of gp160 and gp120 and to determine which
orm of gp160 or gp120 is associated with calnexin or
inds to CD4, the immunoprecipitated samples de-
cribed above were subjected to digestion with endo H
o eliminate the oligosaccharides and then half of the
ample was directly analyzed on reducing SDS–polyac-
ylamide gels and the other half was used for analysis of
rotein on nonreducing SDS polyacrylamide gels.
In agreement with previous reports (Willey et al., 1988;
arl et al., 1991b) for a protein retained in the ER, both
p160 and gp120 were sensitive to endo H digestion
uring the entire 90-min chase period (Figs. 3A and 3B).
fter endoH digestion, both gp160 and gp120 were still
recipitable with the anti-signal peptide antibody and the
eglycosylated gp160 and gp120 migrated as single
olypeptides of 90 and 58 kDa, respectively. Their mo-
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421HIV-1 ENVELOPE PROTEIN SIGNAL SEQUENCElecular masses are identical in size to those predicted
from the amino acid composition of the HIV-1 env gene
RF (Stein and Engleman, 1990; Li et al., 1993). We have
esignated these decosylated proteins as p90 1 S for
p160 and p58 1 S for gp120. The gp160 precipitated
ith either anti-HIV or anti-calnexin antibodies immedi-
tely after its synthesis showed a predominantly single
FIG. 2. Pulse–chase analyses of HIV-1 Env protein association with
vPE8 (B). At 16 h postinfection, cells were pulse-labeled for 10 min wi
four equal parts and immunoprecipitated with antibodies to HIV, HIV-1 E
were analyzed by SDS–10% PAGE. (C and D) The amount of gp160 or g
by densitometry from fluorography shown in (A) and (B) and expresseand with the same mobility as the signal-retained form
f gp160 (p90 1 S). A somewhat fast-migrating protein
c
pand gradually appeared during the chase period, indi-
ating that this protein represents the signal-cleaved
orm of the gp160 product (p90DS). In contrast, a trace
mount of the signal-retained form of gp160 (p90 1 S)
as detected as a CD4 binding protein at the early times
f chase. However, this p90 1 S form was quickly con-
erted into a signal-cleaved form (p90DS) early in the
in and Env protein folding. HeLa cells were infected with vPE16 (A) or
ethionine and chased for 0 to 90 min. Cell lysates were divided into
al peptide, calnexin, and CD4 plus OKT4. Immunoprecipitated proteins
ound to calnexin (filled circles) and CD4 (open circles) was measured
percentage of the maximal amount bound (Li et al., 1996).calnex
th [35S]m
nv signhase and was seen predominantly as a CD4 binding
rotein at later times of the chase. These changes in the
f the c
0 or gp
422 LI ET AL.signal sequence cleavage and association with calnexin
or with CD4 were clearly distinguishable, when the sam-
ples prepared from cells expressing gp120 were treated
with endo H (Fig. 3B). With its more rapid dissociation
with calnexin, only signal-retained forms of gp120 (p58 1
S) were seen as a predominant product associated with
calnexin.
These results establish the slow kinetics of the signal
sequence cleavage in the HIV-1 Env protein and show
that the signal-retained forms of gp160 and gp120 asso-
ciated with calnexin in the ER. With the removal of the
signal sequence, both gp160 and gp120 are folded prop-
erly and can be bound to CD4.
The signal sequence retards the folding of HIV-1 Env
protein
SDS–PAGE under nonreducing conditions has been
widely used to monitor the disulfide bond formation of
glycoproteins and viral membrane proteins (Lodish and
Kong, 1991; Doms et al., 1993). This method takes advan-
tage of an increase in mobility as a protein acquires a
more compact conformation stabilized by the formation
of disulfide bonds and often reflects progressive folding
FIG. 3. Endoglycosidase analysis of signal processing and its relatio
and processed exactly as described in the legend to Fig. 2. Immunopre
after which one-half of each digested sample was directly analyzed on
analyzed on 10% nonreducing SDS–PAGE (see Fig. 4). The mobility o
precursor (p90 1 S and p58 1 S) and the signal-cleaved form of gp16toward the native conformation state. To determine
whether the signal sequence influences the folding ofthe HIV-1 Env protein, the samples prepared with endo
H, as described in Fig. 3, were analyzed by SDS–PAGE
under nonreducing conditions. As shown in Figs. 4A and
4B, both gp160 and gp120 precipitated with the anti-
signal peptide antibody migrated as a broad, diffuse set
of bands during the entire chase period (Figs. 4A and
4B), compared with the single, sharply defined band
revealed in the reducing gel (Figs. 3A and 3B). Consis-
tently, the majority of calnexin-associated gp160 and
gp120 (Figs. 4A and 4B), which were also shown as
signal-retained forms, exhibited the same diffuse pattern
of mobility. This indicates that these changes in gel
mobility are due to alterations in the pattern of disulfide
bonding and are not caused by carbohydrate processing
(Lodish and Kong, 1991). In contrast, both the signal-
cleaved forms of gp160 and gp120 coprecipitated with
the anti-CD4 antibody and migrated as a single, fast-
migrating sharper band at all times up to 90 min of
chase, indicating that with the signal cleavage they un-
dergo conformational changes involving formation or re-
arrangement of disulfide bonds resulting in a single
fast-migrating, compact, folded species (Lodish and
Kong, 1991). It was also noticed that a small fraction of
lnexin association and protein folding. HeLa cells were pulse-labeled
ed gp160 (A) and gp120 (B) were digested with endoH at 37°C for 5 h,
ducing SDS–PAGE followed by fluorography, while the other half was
ompletely deglycosylated but signal-retained form of gp160 or gp120
120 (p90)S and p58)S) is indicated.n to ca
cipitat
10% recalnexin-associated gp160 appeared during the chase,
as a faster migrating band corresponding to the gp160
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423HIV-1 ENVELOPE PROTEIN SIGNAL SEQUENCEcoprecipitated with CD4 (Fig. 4A). Since the majority of
the signal-retained form of gp120 was associated with
calnexin, only the broad bands that represent incom-
pletely folded gp120 were seen in the nonreducing gel
(Fig. 4B). As expected, both the signal-retained and the
signal-cleaved forms of gp160 and gp120 were precipi-
tated with anti-HIV antibodies. These proteins exhibited
mixed forms of migrating patterns under the nonreducing
gel (Figs. 4A and 4B). These results demonstrate that the
uncleaved signal sequence directly interfered with the
folding of the HIV-1 Env protein.
To further confirm the effect of the HIV-1 Env signal
sequence on the protein folding, we have replaced the
signal sequence of the glycoprotein (G) gene of the
vesicular stomatitis virus (VSV) with that of the HIV-1 Env
signal sequence. Expression of this chimeric protein and
the wild-type VSV-G protein was carried out in a vaccin-
ia/T7 transient expression system (Fuerst et al., 1986).
he pulse–chase experiments (Fig. 5A) showed that the
himeric G protein was not only immunoprecipitated with
ntibodies to VSV-G (data not shown), but also precipi-
ated with antibodies to the signal peptide of the HIV-1
nv protein, indicating the slow and inefficient cleavage
f the HIV-1 Env signal sequence from the VSV-G protein.
hen the samples were analyzed by SDS–PAGE under
FIG. 4. Analysis of effect of the signal sequence on the folding of the
A) and gp120 (B) digested with endoH as described in the legend toonreducing conditions, the chimeric G protein precipi-
ated with the anti-signal peptide antibody also migrated
p
os a broad, diffuse set of bands (Fig. 5B). In contrast, the
ild-type VSV-G protein migrated as a single, sharper
and. To further determine whether or not the slow cleav-
ge of the HIV-1 Env signal sequence would alter intra-
ellular transport of the chimeric VSV-G protein, we ex-
mined acquisition of endo H resistance by the chimeric
rotein. As can be seen in Fig. 5C, the wild-type VSV-G
rotein became completely resistant to endo H by 1 h,
ndicating normal transit to the Golgi compartment (Ad-
ms and Rose, 1985). In contrast, approximately 50% of
he chimeric VSV-G protein remained endo H-sensitive,
ndicating that these proteins are not transported to the
olgi.
DISCUSSION
Translocation of secretory and membrane proteins
rom the cytoplasm into the ER is a multistep process
equiring a functional signal peptide. Therefore, the sig-
al sequence must perform several functions that are
nown to be required for efficient translocation, such as
ecognition and binding to the SRP, interaction with
embrane-bound components of export machinery,
pening the protein conducting channels to initiate
ranslocation, and appropriate presentation to the signal
Env protein by nonreducing SDS–PAGE. Immunoprecipitates of gp160
ere analyzed by 10% nonreducing SDS–PAGE.eptidase for cleavage (Johnson, 1997). Poor recognition
f a signal sequence of a polypeptide at the early stage
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424 LI ET AL.of its transport may result in mistargeting. However,
direct characterization in vivo of the signal cleavage and
its effect on protein biosynthesis has been hampered
because of the difficulty of raising antibodies against
hydrophobic signal peptides (Lyko et al., 1995).
As part of our study on the role of the signal sequence
FIG. 5. Effect of the HIV-1 Env signal sequence on the folding and
ntracellular transport of the VSV-G protein. BHK cells were infected
ith a recombinant vaccinia virus encoding T7 RNA polymerase and
ransfected with plasmid DNA (encoding the wild-type VSV-G protein)
r the DNA encoding the chimeric VSV-G (G/HIV-SP). After 16 h the
ells were pulse-labeled with [35S]methionine for 10 min and chased for
he times indicated. The wild-type VSV-G and chimeric VSV-G proteins
ith HIV-1 Env signal sequence were immunoprecipitated with anti-
odies against VSV-G and the HIV-1 Env signal peptide, respectively.
mmunoprecipitated proteins were analyzed on 10% reducing (A) or
onreducing (B) SDS–PAGE followed by fluorography. (C) BHK cells
xpressing the wild-type VSV-G and chimeric VSV-G proteins were
abeled with [35S]methionine for 10 min and chased for 1 h. Cell lysates
ere immunoprecipitated with anti-VSV-G antibodies. Immunoprecipi-
ates of VSV-G proteins were divided in half and either digested with
ndoH (1) or mock digested (2) before analysis on 10% SDS–PAGE.f the HIV-1 Env glycoprotein in protein biosynthesis,
olding, and trafficking, we have examined the kinetics of
c
wthe signal peptide cleavage in several mammalian cell
lines and its relation to protein folding and association
with calnexin. Using a pulse–chase experiment com-
bined with specific antibodies raised against the HIV-1
Env protein signal peptides, we have been able to dem-
onstrate that cleavage of the signal sequence of gp160
and gp120 was highly inefficient in three different cell
lines where the t 1/ 2 of the signal sequence cleavage is
pproximately 60 min. These results confirm and extend
ur previous observation in insect cells that the slow and
nefficient cleavage of the signal sequence is a general
henomenon, which is due to an intrinsic property of the
ignal sequence of the HIV-1 Env protein (Li et al., 1994,
996). Our results are consistent with a recent report that
howed that cleavage of the signal sequence from gp160
as very inefficient in an in vitro coupled translation–
ranslocation system (Martoglio et al., 1997).
A major difference between the HIV-1 Env protein
ignal sequence and typical eukaryotic signal peptides
s the presence of a number of charged residues in the
-region (Li et al., 1994; Pancino et al., 1994). A sequence
omparison of 185 eukaryotic signal peptides revealed
hat none have more than five charges and more than
50 have a single charged residue or no charged resi-
ues in their n-region (Pancino et al., 1994; Watson,
984). It has been suggested that the positively charged
mino acids may play a crucial part in determining the
fficiency of the protein secretion (Boyd and Beckwith,
990; von Heijne, 1984). Indeed, previous studies have
hown that distinctive features, such as a long and highly
harged n-region in the HIV-1 signal peptide, do not
eem to influence dramatically the primary translocation
unction of the signal sequence (Ellerbrok et al., 1992; Li
t al., 1994) but rather interfere with the rate of cleavage
f the signal peptide in HIV-1 gp120, thus being respon-
ible for its slow rates of folding, intracellular transport,
nd thereby secretion (Li et al., 1996). Similar effects of
he inhibition of the signal sequence cleavage on protein
ecretion have been noted. For example, failure to cleave
he signal peptides of the yeast acid phosphatase
Haguenauer-Trapis and Hinnen, 1984) or invertase
Schauer et al., 1985) leads to a retention of the core
lycosylated proteins in the ER, thereby slowing their
verall rate of transport to the cell surface. Others have
hown that inefficient cleavage of the signal sequence
ay interfere with proper folding of the targeted proteins
Kuhn and Wickner, 1985) or lead to aggregation and
isfolding (Hurtley and Helenius, 1989; Shaw et al.,
988). What then is the function of signal peptide cleav-
ge? It has been suggested that folding of membrane
roteins and perhaps secretory proteins is influenced by
he signal peptides (Wickner, 1979; Hurtley and Helenius,
989; Wilkinson et al., 1997). If so, signal peptide cleav-
ge early in the biosynthesis of a precursor protein could
ontrol entry to the correct folding pathway. Consistent
ith this suggestion, Park et al. (1988) have demon-
425HIV-1 ENVELOPE PROTEIN SIGNAL SEQUENCEstrated in vitro, by examining the folding kinetics of the
purified precursor and the mature forms of maltose bind-
ing protein and ribose binding protein, that the presence
of signal sequences inhibits the folding of the mature
portion of the exported proteins, thereby allowing their
capture by chaperones such as SecB (Liu et al., 1989)
and preventing the cytoplasmic formation of a stable
structure that could block the translocation mechanism
(Duong et al., 1997). This is consistent with our findings
that the majority of newly synthesized but signal-retained
gp160 and gp120 remained as an unfolded or incom-
pletely folded form. This was demonstrated in nonreduc-
ing gels, where these glycoproteins remained associ-
ated with calnexin, strongly suggesting that an un-
cleaved signal sequence is indeed one of factors that
inhibits the folding of the HIV-1 Env protein. Thus its long
residence within the ER and its prolonged association
with calnexin are a consequence of its slow cleavage (Li
et al., 1996; Otteken and Moss, 1996).
Viruses use many strategies to escape immune detec-
tion. They can interfere with antigen presentation or
block signal transduction pathways. The conservation of
lentiviral signal sequences has prompted speculation
about alternative functions (Pancino et al., 1994). Frag-
ments derived from the signal sequence of some secre-
tory or type I membrane proteins have been found asso-
ciated with MHC class I molecules and are transported
to the cell surface for presentation to cytolytic T cells.
Some signal peptide fragments corresponding mainly to
the C-terminal segment of the respective signal se-
quence become associated with MHC class I molecules
independent of the transporters associated with antigen
processing (TAP) (Henderson et al., 1992; Wei and Cres-
swell, 1992). Interestingly, one signal peptide fragment
derived from the n-region of the lymphocytic choriomen-
ingitis virus envelope protein has been shown to un-
dergo strictly TAP-dependent binding to MHC class I
molecules (Hombach et al., 1995). Therefore, it is likely
that peptides derived from the HIV-1 signal sequence
also associate with MHC molecules and may also be
recognized by the cellular immune response. In support
of this prediction, recent studies have shown that the
signal sequence of the HIV-1 Env protein has the char-
acteristic feature for calmodulin (CaM) binding in its
n-region and that the cleaved signal peptide fragment of
gp160 is released into the cytosol and interacts effi-
ciently with CaM (Martoglio et al., 1997). Other studies
have shown that in HIV-1 infected cells several CaM-
dependent processes involved in immune defense are
disrupted; one mechanism by which this may be
achieved is the binding of CaM to the cytoplasmic do-
main of the gp41 protein (Miller et al., 1993). These
results suggest that additional binding of CaM by the
HIV-1 signal peptide may further contribute to inactiva-
tion of CaM-dependent processes in infected T cells
(Martoglio et al., 1997; Srinivas et al., 1993).Although the biological significance of the conserva-
tion of an unusually long n-region in most of the HIV-1
Env signal sequences remains to be elucidated, the
findings that the slow and inefficient cleavage of the
signal sequence of the HIV-1 Env protein has profound
effects on the protein folding, interaction with calnexin,
and intracellular transport suggest that the HIV-1 signal
sequence not only plays an important role in biosynthe-
sis of the Env protein, but also has some biological
importance. The efficiency of HIV-1 replication in vivo
with a heterologous signal sequence would reveal the
necessity of inefficient processing of the HIV-1 Env pro-
tein biosynthesis and virus–host cell interactions. It may
be possible to generate a highly productive HIV-1 by
replacing the glycoprotein signal sequence with more
efficient signal sequences from other glycoproteins. It is
known that the signal sequence coding region of HIV-1
encodes, in a different coding frame, approximately 30
carboxy-terminal amino acids of vpu and might thus act
as a buffer region during adaptive mutations (Ellerbrok et
al., 1992). In contrast to HIV-1, HIV-2 has no vpu and no
described function in the region of the signal sequence.
It is also reported that the disease progresses much
more slowly with HIV-2 infection (Marlink et al., 1994).
Therefore, it is tempting to speculate that HIV-1 may have
adopted a strategy of selecting the envelope protein for
prolonged ER retention via a slow-folding pathway me-
diated by the atypical signal peptide sequence. This
process retards its overall rate of Env protein transport
through the secretory pathway and thereby delays its
display on the cell surface and further delays its detec-
tion by the host’s immunological surveillance system.
Alternatively, the uncleaved signal sequence on the
HIV-1 Env protein precursor may have some further neg-
ative effects; continued synthesis of an aberrant mem-
brane-bound protein and its accumulation may perturb
ER membrane function in vivo, which ultimately leads to
the destruction of the cells, since it has been demon-
strated that signal sequences strongly interact with
membranes (Verner and Schatz, 1988). Together, these
recent studies suggest that signal sequences may be
functionally more versatile than previously anticipated
(Martoglio et al., 1997). A systematic approach to study
the signal sequence of the HIV-1 Env protein will lead to
a better understanding of the function of the signal se-
quence in addition to protein targeting and translocation.
MATERIALS AND METHODS
Cells, viruses, and reagents
HeLa and BHK21 cells were maintained in Dulbecco’s
modified Eagle’s medium containing 10% fetal bovine
serum (FBS). Jurkat cells were maintained in RPMI 1640
medium supplemented with 10% FBS. Recombinant vac-
cinia viruses used in this study include vPE16, vPE8, and
vTF7-3, which expresses, respectively, the entire HIV-1
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426 LI ET AL.env gene gp160, gp120, and T7 RNA polymerase, pro-
vided by P. Earl and B. Moss (Earl et al., 1991a). Human
IV immune globulin and sheep anti-HIV-1IIIB gp120
erum were provided by A. Prince (1991) and M. Phelan
Page et al., 1992), respectively. All viruses and antibod-
es were obtained through the NIH AIDS Research and
eagent Program. The plasmid pWK1, which contains the
ull-length G gene of VSVIND, was kindly provided by R. R.
agner (Keil and Wagner, 1989). Rabbit anti-signal pep-
ide serum and anti-calnexin antibody were used as
reviously described (Li et al., 1996). Soluble CD4 and
onoclonal antibody, OKT4, were from American Bio-
echnologies and Ortho Diagnostics and used as de-
cribed previously (Li et al., 1993).
lasmid constructions
To replace the signal sequence of VSV-G protein with
hat of the HIV-1 Env protein, we first constructed a
SV-G with deletion of its own signal sequence of 16
mino acids (VSV-GDS) by PCR amplification. The oligo-
ucleotide primers 59-GGCGGATCCGCATGCAAGT-
CACCATAGTT-39 (forward) and 59-GGCGGATCCT-
ACTTTCCAAGTCG-39 (reverse) were used and ampli-
ied with the Gene Amp kit as previously described (Li et
l., 1994). The primers had BamHI sites at their 59 termini
so that the amplified VSV-GDS DNA fragment could be
inserted into the BamHI site of the Bluescript II vector
SK(1) under control of the T7 promoter (Stratagene). In
addition, there is a SphI site created between the BamHI
site and the first coding sequence AAG (lys) of VSV-G in
the forward primer, which was designed for insertion of
the HIV-1 Env signal sequence. The resulting plasmid
was designated pBS-GDS. The DNA fragment coding for
the signal sequence of the HIV-1 env gene was amplified
from pBS-gp120-NSS by PCR using the two primers 59-
AATACGACTCACTAT-39 (corresponding to the T7 pro-
oter sequence) and 59-GGCGCATGCACTACAGAT-
AT-39 (reverse), in which a SphI site was created. The
mplified DNA fragment containing the env signal coding
equence was digested with XhoI and SphI and inserted
into the XhoI- and SphI-digested vector pBS-GDS, result-
ing in the recombinant plasmid pBS-G-NSS. In addition,
pWK1 was digested with XhoI and the insert DNA coding
for the VSV-G gene was also cloned into the XhoI site of
the Bluescript II vector SK(1) under control of the T7
promoter. DNA sequences were confirmed by the chain-
terminator method (Sanger et al., 1977).
Expression, metabolic radiolabeling, and
immunoprecipitation
HeLa, BHK21, or Jurkat cells were infected with recom-
binant vaccinia virus (vPE16 or vPE8) at a multiplicity of
infection of 30 plaque-forming units per cell. At 16 h
postinfection, cells were placed in a methionine-free
medium for 30 min, after which they were pulse-labeledfor 10 to 15 min (as specified in each figure’s legend) with
[35S]methionine (500 mCi/ml). One sample was lysed
immediately, while others were chased by removing the
radioactive medium and replacing it with a normal me-
dium supplemented with a 10-fold excess of cold methi-
onine. The method for the infection and transfection is
based on the procedure of Fuerst et al. (1986). Cells were
lysed with 1% Nonidet-P40 in 150 mM NaCl, 50 mM Tris
(pH 8.0), 1 mM phenylmethylsulfonyl fluoride (Li et al.,
1996), incubated on ice for 15 min, and centrifuged for 5
min; 10 mM iodoacetamide was included in the lysis
buffer for experiments in which disulfide bond formation
or calnexin association was determined. The cell extract
was incubated for 12 h at 4°C with the appropriate
serum; for quantitative immunoprecipitation (.90%) of
total labeled gp160 or gp120, a mixture of antibodies
(human HIV immune globulin and sheep anti-gp120 se-
rum) was used, after which protein A–Sepharose was
added for 1 h. The precipitated immune complexes were
washed three times with lysis buffer as described above.
Samples were prepared in a dissociation buffer (Li et al.,
1993) and analyzed by SDS–10% PAGE followed by fluo-
rography. Quantification was performed with the Image-
Master desktop scanner (Pharmacia).
Endoglycosidase analysis
Immunoprecipitated proteins were eluted by boiling
for 10 min (Li et al., 1993) from protein A–Sepharose in
20ml of 1% SDS–50 mM Tris and digested with endoH
New England Biolab) for 5 h at 37°C in the buffer
rovided by the manufacturer. Digested samples were
ivided into two equal aliquots. One aliquot was mixed
ith an equal volume of 23 reducing sample buffer, and
he other was mixed with an equal volume of 23 sample
buffer omitting 2-mercaptoethanol for nonreducing gels
(Lodish and Kong, 1991).
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